TCMD | tickerfilter.com

Fundamental analysis

27%

Profitability 42%

Dept financing 17%

Liquidity 42%

Performance 10%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

4.90%

1 Month

7.20%

3 Months

5.96%

6 Months

-12.47%

1 Year

-28.92%

2 Year

62.98%

Key data

Stock price

$13.68

P/E Ratio

9.98

DAY RANGE

N/A - N/A

EPS

$1.36

52 WEEK RANGE

$9.70 - $19.11

52 WEEK CHANGE

-$0.28

MARKET CAP

325.304 M

YIELD

N/A

SHARES OUTSTANDING

23.762 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/04/2024

BETA

1.13

PUBLIC FLOAT

AVERAGE 10 VOLUME

$113,795

AVERAGE 30 VOLUME

$156,380

Company detail

CEO: Gerald Mattys
Region: US
Website: https://www.tactilemedical.com/
Employees: 871
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

tactile medical is one of the fastest growing companies in medical devices. as a leader in treatment options for lymphedema and venous ulcer therapies, tactile medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling . headquartered in minneapolis, minnesota, we advocate for patient access and serve tens of thousands of patients through a direct national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff.

TCMD - Tactile Systems Technology Inc